Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 6, 2024CureusOpen Access

Risk of Aspiration Pneumonitis After Elective Esophagogastroduodenoscopy in Patients on Glucagon-Like Peptide-1 Receptor Agonists

View Full Paper
Ask AI
Bookmark
Share

Authors

RARuaa Al Sakka AminiAIAbdellatif IsmailMAMaysarah Mahdi Alaqrabawi

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Amini et al. (2024) studied this question.

synapsesocial.com/papers/68e5d358b6db643587569d06https://doi.org/10.7759/cureus.66311
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Peri-Procedural Safety of GLP-1 Receptor Agonists in Elective Endoscopy: A Multicenter Retrospective Cohort Study2025 · 1 citations
  2. 2Impact of Glucagon‐Like Peptide‐1 Receptor Agonists on Retained Gastric Contents During Esophagogastroduodenoscopy: A Propensity Score‐Matched Study2025
  3. 3Confounding Factors in the Association Between Glucagon-Like Peptide-1 Receptor Agonist Use and Retained Gastric Contents in Asymptomatic Patients Undergoing Upper Gastrointestinal Endoscopy: A Retrospective Study2024 · 3 citations
  4. 4Evaluating Glucagon-Like Peptide-1 Receptor Agonist Safety Before Upper Endoscopy: A Systematic Review and Meta-Analysis2026
  5. 5Glucagon-like Peptide-1 Receptor Agonists and Upper Gastrointestinal Endoscopy: A Narrative Review of Residual Gastric Contents Aspiration Risk and Periprocedural Management2026